11th Annual Career Day 2017
Date: Friday May 5th, 2017
Time: 8:30 AM – 5:00 PM
Location: Bahen Centre for Information Technology
— To help you prepare, we recommend that you attend the LSCDS Getting the Most Out of Career Fairs seminar —
8:30 – 9:00 Registration
9:00 – 10:00 Keynote Speaker
10:00 – 12:00 Panel Discussion Session
12:00 – 13:30 Lunch
13:30 – 17:00 Company Information Fair
14:00 – 16:00 Spotlight Sessions
NOTE: Registration will open Friday April 21th, 2017.
**LSCDS Career Day is free of charge to students and trainees at U of T. Please log in to access free tickets.
Keynote Speaker: Dr. Anne Mullin
Dr. Anne Mullin works with leading decision-makers across the HealthSphere to amplify the impact of biomedical discoveries and healthcare innovations on the health and wellbeing of populations in both developed and developing countries.
Dr. Mullin’s collaborative approach to working with clients and rich academic track record in the study of infectious disease have supported the sustainability and success of numerous international product development consortia, allowed both industry and academic partners to manage risk of high-impact clinical trials, and helped clients from industry, academia and the not-for-profit sector attract capital, establish partnerships and drive innovation. Having led engagements in North America, Europe, Southeast Asia and Africa, Anne’s client base spans the globe.
Prior to joining Shift Health, Dr. Mullin was a postdoctoral fellow and lecturer in the department of Pathology and Laboratory Medicine at the University of British Columbia. While at UBC, she was also a committed leader in the public communication of science within British Columbia and Director of the Society for Canadian Women in Science and Technology. Dr. Mullin graduated with a MSc from the London School of Hygiene and Tropical medicine, a PhD in virology from The University of Cambridge and an MBA from the Richard Ivey School of Business, where she specialized in healthcare and life sciences strategy.
NOTE: To learn more about a particular guest, scroll down to see his/her biography.
Panel Session A
|Kelly Seto||Product Development Scientist||Axela|
|Marni Williams||Analyst/Consultant||Shift Health|
|Dennis Ng||Business Development Analyst||the Centre for the Commercialization of Antibodies Biologics|
|Nathalie Budd||Medical Science Liaison||Hoffmann La Roche|
|Laleh Sinai||Clinical Research Associate||Purdue Pharma Canada|
|Devon Metcalf||Infection Prevention and Control Professional||Guelph General Hospital|
|Frank Shannon||VP, Clinical Development and Regulatory Affairs and Quality||Interface Biologics|
Panel Session B
|Lisa Johnson||Research Scientist||Trillium Therapeutics Inc.|
|Youssef Hayek||Analyst/Consultant||Shift Health|
|Akshita Vincent||Business Development Analyst||The Hospital for Sick Children|
|Mark Surka||Scientific Advisor||Janssen Pharmaceuticals|
|Lisa Tanser||Director and Line Manager in Country Clinical Operations||Hoffmann La Roche|
|Natalie Farra||Senior Acquisitions Editors||Elsevier|
|Bruce Seet||Director of Medical Affairs||Sanofi Pasteur|
Panel Session C
|Vera Madzarevic||Director of R&D||Global Research Pharma Canada|
|Wendy Dobson-Belaire||Forcasting Lead||GSK|
|Steven Molinski||Application Scientist||Cyclica|
|Aileen Zhou||Senior Regulatory Affairs Specialist||Synaptive Medical|
|Jasmine Dautovich||Project Manager||ScarX Therapeutics|
|Srdjana Filipovic||Knowledge Translation Program Manager||The Hospital for Sick Children|
|Brett Hogan||Director of Customer Strategy||Hoffmann La Roche|
Dr. Dobson-Belaire obtained a PhD from the Department of Molecular Genetics at U of T working with Scott Gray-Owen in the areas of infectious disease and immunology. She also has a Health Sector-focused MBA from the Richard Ivey School of Business at Western.
In her spare time, Dr. Dobson-Belaire is kept very busy with joys of being a mom of two young sons but also looks forward to the occasional few moments of peace to read a good book or fall into the world of an HBO mini-series.
Prior to joining Shift Health, Dr. Hayek was a post-doctoral fellow at the University Health Network in Toronto. Dr. Hayek graduated with a PhD in Physiology from the University of Toronto and a MBA in Finance from Queen’s School of Business at Queen’s University. He has authored 13 publications and is a recipient of the Alzheimer’s Society of Canada Doctoral Training Award and the Canadian Institutes of Health Research Science to Business Award.
Outside of work, he is an active oenophile (the founder of Queen’s MBA wine club and facilitated wine-tasting events for colleagues at Shift Health’s annual retreat), a voracious reader (completed the majority of Time magazine’s and the Modern Library’s top 100 books), and a sport enthusiast (avid fan and participator of soccer and tennis).
During the past 18 years in Pharma, Mr. Hogan has held positions of increasing responsibility in sales and marketing management at Roche Canada. A demonstrated leader who has developed strategic skills at each stage of his career, Mr. Hogan is currently the Director of Customer Strategy for Ontario and Atlantic Canada and prior to that was a Business Unit Director at Roche responsible for numerous therapeutic portfolio’s during his 12 years of directorship at Roche.
His strong understanding of science and Bio-Chemistry background has helped keep him organized with a clear vision for the big picture and able to structure the business environment in a way that maximizes cross functional collaboration and teamwork. Holding a Degree in Education also enables him to provide guidance and strategic direction to lead employees through times of change in the healthcare environment. Additional business focus has enabled Mr. Hogan to make quick strategic decisions to position the products of Roche in a favourable manner to patients and health care providers.
Mr. Hogan has recently embarked upon a new journey at Roche, focusing on the needs of Ontario and Atlantic Canada accountable for all Roche promoted products. He is responsible for achieving business results and the development & implementation of unique regional strategies to further distinguish Roche as a leader of Innovation. This will lead to improved identification of opportunities that positively impact Roche, our customers and patients – now and into the future.
Outside of work when not playing hockey, he enjoys camping with his wife Susan, and three daughters Chelsea, Caitlin and Fiona and travelling back and forth to gymnastics, Karate and volleyball!
Dr. Johnson received her BSc (Hons) in Biology/Biotechnology from Carleton University and her PhD from the University of Minnesota’s Microbiology Immunology and Cancer Biology program. Her dissertation research was focused on the regulation of CD8+ T cell homeostatic proliferation. She completed her post-doctoral fellowship at the BC Cancer Agency’s Vancouver Island Centre, where she studied the immune response of cancer patients receiving radiation therapy and where she learned to kayak.
Prior to IBI, Mr. Shannon has worked for large and medium pharmaceutical companies including Ciba-Geigy, Genentech, Roche and Boehringer Ingelheim where he led Medical Affairs for cardiovascular and cerebrovascular disease areas in Canada, as well as late phase clinical development projects, globally. Subsequently, he moved to the medical device sector, joining Occulogix as the Director of Clinical and Outcomes Research. More recently, he held executive positions in Regulatory Affairs and Quality Assurance at St. Jude Medical and Baxter Corporation, in Canada. Following his bachelor’s degree in Psychology at Brock University, Mr. Shannon undertook graduate studies in Epidemiology at the University of Toronto and the Institute for Clinical Evaluative Sciences.
Outside of work, Mr. Shannon enjoys spending time in the woods or on the water – camping, hiking and canoeing with his wife, son and twin daughters.
Dr. Bruce Seet earned a B.Sc (Honours Human Physiology) and a Ph.D. (Microbiology and Immunology) from Western University (London, Canada), followed by a postdoctoral research fellowship at the Lunenfeld Research Institute at Mt. Sinai Hospital (Toronto). After a decade of research in academia, Dr. Seet joined GlaxoSmithKline (GSK) in 2006 where he held a variety of roles supporting a range of therapy areas such as vaccines, oncology and other specialty care products over 8 years. While at GSK, he completed his MBA at the Rotman School of Management (Toronto). He joined Sanofi Pasteur in 2014 where he resides presently as a Director of Medical Affairs.
Among his volunteer activities, Dr. Seet serves as a mentor and coach to young scientists and is the President and founder of the Science to Business Network, a grass-roots organization that promotes the professional development of young scientists as well as innovation in Canada by connecting industry and academia. He also serves on the Research Management Committee as well the HQP Development Committee for BioCanRx, a Network Centres of Excellence (NCE) that accelerates the clinical development of promising cancer immunotherapies in Canada.
In Dr. Seto’s spare time, you may find her taking advantage of the vibrant art scene in the city with a camera in hand, or enjoying some wonderful cuisine with her family and friends.
Her company is a leader in research and development of medicines for the treatment of pain and central nervous system disorders (ADHD) and a growing pipeline of prescription and over the counter products.
She completed her M.Sc. in Molecular Biology, Cell Biology and Genetics at the University of Heidelberg in Germany. Then she moved to Toronto to pursue a Ph.D. in Medical Science and Neuroscience followed by a postdoctoral position in the field of Neuronal Stem Cell Research at the University of Toronto and the Hospital for Sick Children.
In her spare time, she enjoys meditation, reading books, working out, camping, nature hikes and spending time with her family.
Ms. Tanser holds a Master’s of Science degree from the University of Toronto under the Institute of Medical Science with a focus on sleep physiology and neuropsychiatry. Her thesis examined level of self-efficacy in predicting outcomes for insomnia patients using behavioral techniques to improve sleep quality and duration. She also holds an Honours Bachelor of Science from Brock University in Neuroscience.
While at Roche, Ms. Tanser was also a Director and Site Head for Product Development Regulatory department and a member of Roche Mississauga’s Leadership Team. Prior to joining Roche, Ms. Tanser was with i3, a Contract Research Organization as an Associate Director of Medical Writing and Scientific Communications for a large partnership managing a team of 50+ individuals across Canada, the United States and India. Prior to i3, Ms. Tanser was with AstraZeneca for nearly 10 years as a Clinical Scientist and later, Clinical Manager focusing on their GI portfolio.
In her free time, Ms. Tanser enjoys being active and outdoors running, cycling, yoga, hiking and skiing. She can also be found in many hockey arenas across southern Ontario cheering her children on from the stands if she’s not in the box playing music for the game and helping her husband keep score.
Ms. Vincent has a Master’s degree from the Institute of Medical Sciences, University of Toronto. Her Master’s thesis was titled, “Epigenetic alterations associated with uropathogenic E.coli infections”. She also did a Graduate Certificate Diploma in Bioinformatics from Seneca College, Toronto. Her previous work experience includes being a Clinical Lab Manager, Academics & Funding Commissioner, Physical & Life Sciences at UTGSU, volunteering at the Critical Care Unit at SickKids and Research Administrative Assistant at SickKids. In her free time, Ms. Vincent enjoys spending time with her family, hiking and camping in some of the remotest parts of the world, reading (her current read being Terry Pratchett’s The Last Continent) and dancing.
Dr. Aileen Zhou is a Senior Regulatory Affair Specialist at Synaptive Medical Inc., a medical device and technology company that is transforming the healthcare in and beyond the operating room. Dr. Zhou has more than 10 years of experience in medical devices and biologics R&D, commercialization, and regulatory affairs. Prior to Synaptive, Dr. Zhou was a vital member of a Toronto-based biotech startup, which she helped establish through her doctoral research. In addition to the involvement in scientific and clinical affairs, she was responsible for the entire regulatory portfolio of complex combination devices for bone regeneration. Dr. Zhou studied Engineering Science at the University of Toronto, followed by a Masters and a PhD in Tissue Engineering, also from the University of Toronto.
Amaris is an independent, international Technologies and Management Consulting Group. Created in 2007, Amaris is already established in over 50 countries and supports 700 clients worldwide throughout their projects’ lifecycle. Our expertise covers 5 areas of innovation: Business and Management, IT/IS, Telecom, Engineering and High Technologies, Biotech and Pharma. With 65 offices across the World, the Group offers proximity support to its clients in all their locations and many opportunities of international careers for employees. With an average age of 26 years old for staff members and 34 years old for consultants, Amaris benefits from an agile structure and a start-up innovative spirit.
Thus Amaris innovates both Management policies, by hiring, trusting and giving responsibilities to young talents, and in technologies by internally developing its own ERP system made of more than 200 applications.
In 2017, Amaris will reach a turnover of 180 million euros, 3500 employees and the ability recruit 1 new employee every 5 hours. We expect to triple our workforce within the next years and reach an international leader position in independent consulting.
BenchSci is an open-access online platform that uses machine-learning to decode research papers and extract antibody usage data. Our goal is to help scientist find the best antibody for their experiments.
Welcome: Students, New Graduates, Mentors & Sponsors:
The Faculty Club is considered one of the finest clubs at any Canadian University. Charm and elegance reminiscent make the Club a haven for on-campus socializing. Whether you prefer a more refined setting for a luncheon or networking session or a pub atmosphere to a enjoy a glass of wine, a pint of beer and sample our Bit’s & Bites menu, the Faculty Club has something for everyone. Membership is affordable and limitless in its offerings.
FIVE MAIN REASONS TO BECOME A FACULTY CLUB MEMBER:
• Network with today and tomorrows academic and industry leaders
• Outstanding venue space for business and social events.
• Ability to travel the world through the Association of Colleges & Universities Clubs and obtain discounts on accommodation and more.
• Reciprocity with the International Associate Clubs; a collection of resorts & country clubs around the world.
• Join our year round club events; wine tasting clubs, speaker series, book clubs and other social activities.
Membership has its Privileges!
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Your Content Goes Here
Why Work for Roche?
Every day we help improve the health and quality of life of Canadians. Our corporate culture, characterized by the values of integrity, courage and passion, helps to make us the leader in the Canadian pharmaceutical and in vitro diagnostics market.
At Roche, we have developed a culture where we encourage our employees to do now what patients need next.
We provide innovative high-quality products and services; go above and beyond the normal course of business to delight our customers and build valued, long-term relationships; provide a high-performing, rewarding and supportive work environment where people want to grow; and demonstrate ethical and socially responsible behaviors.
Roche has three values: integrity, courage and passion. These values, which represent the Roche Group as well as our Canadian entity, describe the expected behaviors, the attitude and the way we should interact with our customers and colleagues. These values are the foundation of our identity. Integrity Passion Courage
iamsick.ca provides health IT infrastructure to the various stakeholders of our healthcare system including patients from a wide and inclusive demographic spectrum who deserve equitable healthcare access, healthcare professionals looking for cost-saving measures, and healthcare authorities and government agencies in need of access to accurate and near-real-time information about healthcare resource availability. Our website, iOS/Android apps, white-labelled websites/apps, and backend infrastructure fills the needs of all of these stakeholders, and accomplishes it with a focus on optimizing user-experience. We are gaining traction among “hard-to-obtain” clients from both the public & private sectors across Canada. While we are laser focused on improving Canada’s health-care navigation system and growing our business, our team works on various projects simultaneously. These include our marketing and sales campaigns, improving user-experience through design thinking and software development, bidding on RFPs and RFQs, and expanding our cross-disciplinary partnership base.
LeungLaw is a business and intellectual property (IP) law firm that is simplifying the delivery of legal services for entrepreneurs and innovators.
Your Content Goes Here
Your Content Goes Here
Nikon Instruments, (Canada) Inc. is a world leader in the development and manufacture of optical and digital imaging technology for biomedical applications. Now in its 99th year, Nikon provides complete optical systems that offer optimal versatility, performance and productivity. Cutting-edge instruments include microscopes, digital imaging products and software.
OICR is a not-for-profit translational cancer research institute focused on accelerating research discoveries for the benefit of patients and the Ontario economy.
Your Content Goes Here
Therapure Biopharma Inc. is a biopharmaceutical company focused on complex biological therapeutics and technologies. It is comprised of three divisions: Therapure Biomanufacturing which provides contract development and manufacturing (CDMO) services to global clients; Therapure Innovations, focused on research and development of proprietary therapeutics and platform technologies in the areas of anaemia, liver disease and organ preservation; and Therapure Biologics dedicated to the development of plasma protein therapeutics through an innovative proprietary manufacturing technology.